摘要
【摘要】目的研究高迁移率族蛋白1(HMGBl)在卵巢子宫内膜异位症中的表达,为子宫内膜异位症的早期诊断、治疗及预后提供新的思路。方法采用RT—PCR和western—blotting检测HMGBImRNA和HMGBl蛋白在69例卵巢子宫内膜异位症患者异位子宫内膜和在位内膜及69例非子宫内膜异位症患者的在位内膜中(对照组)的表达情况。结果HMGBlmRNA在卵巢异位子宫内膜、在位内膜和非异位症的在位内膜均有表达,其表达灰度值分别为:0.5438±0.0565、0.3016±0.0614、0.1536±0.0444;HMGBl蛋白在三组内膜中表达的灰度值分别为:0.8399±0.0287、0.4010±0.0643、0.1999±0.0716。三组HMGBlmRNA、HMGBl蛋白的表达水平比较差异均有统计学意义(F=8.756,P〈0.05)。HMGBl在各组不同月经时期表达水平比较差异均无统计学意义(P〉0.05)。卵巢子宫内膜异位症患者临床分期高级别异位内膜中HMGBl表达水平高于低级别者(t=10.28,P〈0.01),与肿瘤大小、患者年龄无明显相关(P〉0.05)。结论HMGBl在卵巢子宫内膜异位、在位内膜中呈高表达,且临床分期级别越高其表达增强,其可能在卵巢子宫内膜异位症的发生、发展中起着重要的作用,可作为子宫内膜异位症的生物标记物。
[ Abstract ] Objective To investigate the expression of high mobility group protein boxl ( HMGB1 ) in ovarian endometriosis tissue and to provide new idea for early diagnosis, treatment and prognosis of endo- metriosis. Methods The levels of HMGB1 in ectopic endometrium and eutopic endometrium of 69 patients with ovarian endometriosis and endometrium of 69 cases with non-endometrioses were detected by reverse transcription-polymerase chain reaction (RT-PCR) and Western-blotting. Results HMGB1 was expressed in all the three groups ( ectopic endometrium eutopic endometrium endometrium with non - endometrioses). The relative expression level of HMGB1 mRNA was 0. 54383 4± 0. 0565, 0. 3016 4± 0. 0614, and 0. 1536 4± 0. 044n., respectively ( F = 377. 923, P 〈 0. 0001 ). The relative of HMGB1 protein was 0. 83990 + 0. 12869, 0. 40100 4. 0. 16425, and 0. 19986 + O. 08162, respectively ( F = 185. 625, P = 0. 0000). The expression level of HMGB1 was related to clinical stages ( t = 10. 28, P 〈0. 01 ) ; however, it was not ob- viously related to age, the diameter of lump, and course of disease ( P 〉 0. 05). Conclusions Over ex- pression of HMGB1 in ovary endometriosis indicates that HMGB1 plays a significant role in occurrence and development of ovary endometriosis. The expression of HMGB1 in endometriosis eutopic endometrium was much higher than that of non-endometrioses endometrium, which supports the eutopic endometrium deter- minism. The overexp^ssion of HMGBI was consistent with clinical stage, which proves that HMGB1 maybe be tighdy associated with the severity of the disease and to likely become biomarker.
出处
《中国医师杂志》
CAS
2013年第10期1349-1352,共4页
Journal of Chinese Physician